alexionpharma.es

alexionpharm.com

Alexion Pharmaceuticals (NASDAQ:ALXN) | Official Corporate Site

Europe, the Middle East and Africa. Sponsored Research and Collaborations. Alexion to Acquire Synageva. For more information click here. No is a word they’ve. Most patients with severe and life-threatening rare diseases live with no effective treatment options and no hope. We develop and deliver treatments that will dramatically transform their lives. No is a word they’ve. No is a word they’ve. Read the Letter to Our Shareholders from Alexions 2014 Annual Report. Our development pipeline is focused on hi...

alexionpharma.ca

Alexion | Official Canada Website

Patient Groups and Resources. Soliris in atypical HUS. Ldquo;No” is a word they’ve heard too often. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. In Canada, Soliris. We are currently conducting clinical tr...

alexionpharma.com

Alexion Pharmaceuticals (NASDAQ:ALXN) | Official Corporate Site

Europe, the Middle East and Africa. Sponsored Research and Collaborations. Alexion to Acquire Synageva. For more information click here. No is a word they’ve. Most patients with severe and life-threatening rare diseases live with no effective treatment options and no hope. We develop and deliver treatments that will dramatically transform their lives. No is a word they’ve. No is a word they’ve. Read the Letter to Our Shareholders from Alexions 2014 Annual Report. Our development pipeline is focused on hi...

alexionpharma.com.au

Alexion | Official Australia Website

Patient Groups and Resources. Why Choose Alexion Australia. Ldquo;No” is a word they’ve heard too often. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. In Australia, Soliris. David Kwasha, Managing Director.

alexionpharma.com.br

Alexion | Official Brazil Website

Web Corporativa de Alexion. Doenças Raras e Ultrarraras. Profissionais da Saúde (área restrita). Por que a Alexion? Nossa meta é disponibilizar inovações médicas onde elas ainda não existem. Em apoio ao Dia Internacional das Doenças Raras de 2015, a Alexion alia-se a associações de pacientes ao redor do mundo. Alexion Brasil (Morumbi Corporate Towers). Avenida Dr. Chucri Zaidan, 1.240 - 18º andar - Cj 1801 - Torre A - Golden Tower. Bairro Vila São Francisco - CEP: 04711-130 - São Paulo - SP - Brasil.

alexionpharma.es

Alexion | Mapa de la Web oficial de España

Web Corporativa de Alexion. Centrados en el paciente. Enfermedades raras y ultra-raras. Hemoglobinuria Paroxística Nocturna (HPN). Síndrome Hemolítico Urémico atípico (SHUa). Grupos de pacientes y recursos. Soliris en la HPN. Soliris en el SHUa. Por qué elegir Alexion Pharma Spain. Consultas de los medios de comunicación. No es una palabra que los pacientes han escuchado con demasiada frecuencia. Para obtener más información sobre empleo en Alexion Pharma Spain. El 23 de septiembre de 2016, más de 1....

alexionpharma.eu

Alexion Pharmaceuticals | Official EU Website

This site uses cookies to give you the best experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details please read our Privacy Information. Europe, the Middle East and Africa. Sponsored Research and Collaborations. EMEA Headquarters, Switzerland. Global Supply Chain Operations, Ireland. Alexion R&D Center, France. Ldquo;No” is a word they’ve heard too often. Mdash; Carsten Thiel, Ph.D. Senior Vice President, EMEA and Asia Pacific. Avenue du Tri...

alexionpharma.fr

Alexion | Site officiel Alexion France

Information concernant les cookies. Ce site web utilise des cookies afin de vous fournir une expérience optimale sur notre site. En continuant à naviguer sur ce site, vous consentez à l’utilisation de cookies. Pour en savoir plus, nous vous invitons à consulter notre page concernant la protection des données personnelles. Site Internet du Groupe Alexion. Transparence des liens d’intérêt. Perception de la maladie. Maladie Rare et Ultra-rare. Syndrome Hémolytique et Urémique atypique. 33 (1) 47 32 36 21.

alexionpharma.ie

Alexion | Official Ireland Website

Rare and Ultra-Rare Diseases. Patient Groups and Resources. Ldquo;No” is a word they’ve heard too often. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. Mdash; Julie O’Neill, EVP, Global Operations. Alexion ...

alexionpharma.in

Alexion | Official India Website

What Sets Us Apart. Breakthrough Medical Innovation for Life-Threatening and Rare Diseases. Alexion is a global biopharmaceutical company focused on serving patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to develop and deliver therapies that will dramatically transform their lives. Mumbai, Maharashtra 400 051. 91 (22) 6154 4141. 91 (22) 6154 4100.

alexionpharma.jp

ホーム | アレクシオン ファーマ

Ldquo;No” is a word they’ve heard too often. 2015年7月6日、ストレンジック アスホターゼ アルファ が低ホスファターゼ症 HPP)治療薬として日本で世界初の製造販売承認を取得. 2015年6月26日、ストレンジック™ アスホターゼアルファ とKanuma™ セベリパーゼアルファ)がCHMPからEUにおける承認勧告を取得. This website is intended only for Japanese audiences.